Detalhe da pesquisa
1.
Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity.
Mol Ther Oncolytics
; 25: 174-188, 2022 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35592387
2.
Intratumoral Electroporation of Plasmid Encoded IL12 and Membrane-Anchored Anti-CD3 Increases Systemic Tumor Immunity.
Mol Cancer Res
; 20(6): 983-995, 2022 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35302641